Clinical Trials Browser

Prostate Carcinoma Metastatic to the Bone × Genitourinary × Clear all

NCT03076203 2025-04-29

Phase IB Trial of Radium-223 and Niraparib in Patients With Castrate Resistant Prostate Cancer (NiraRad)

Phase 1 Completed

Prostate Carcinoma Metastatic to the Bone

NCT02507570 2019-03-19

Open Label Phase Two Study of Enzalutamide With Concurrent Administration of Radium Ra 223 Dichloride in Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Symptomatic Bone Metastasis

Phase 2 Completed

Prostate Carcinoma Metastatic to the Bone